Afitap İçağasıoğlu1, Hatice Şule Baklacıoğlu2, Erkan Mesci1, Yasemin Yumuşakhuylu1, Sadiye Murat1, Nilgün Mesci3. 1. Department of Physical Therapy and Rehabilitation, İstanbul Medeniyet University, Göztepe Education and Research Hospital, İstanbul, Turkey. 2. Department of Physical Therapy and Rehabilitation, Bakırköy Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital, Physical, İstanbul, Turkey. 3. Department of Physical Therapy and Rehabilitation, Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey.
Abstract
OBJECTIVES: This study aims to estimate the annual economic cost per hemiplegic patient in Turkey. PATIENTS AND METHODS: Between September 2014 and December 2014, a total of 84 hemiplegic patients (53 males, 31 females; mean age 61.4±13.5 years; range 28-89 years) with stroke for 12 months were included in the study. Type of cerebrovascular accident and complications were evaluated. Hospital records and data from the relatives of the patients were used to calculate the cost. Annual costs were evaluated starting from first hospitalization. Direct costs were calculated with the sum of hospital care (acute care, diagnostic investigations, treatment and rehabilitation), medications, medical visits, outpatient rehabilitation and orthopedic aids. Indirect costs were calculated by taking the income loss due to absence from work into consideration. Prices of medical resources were obtained from the 2014 Healthcare Implementation Notification payment list. RESULTS: At the end of the study, the average direct cost and indirect cost per patient were calculated respectively as 10,594.90±6,554.20 Turkish liras and 9,357.10±10,195.60 Turkish liras (4,606.47±2,849.65 USD and 4,068.30±4,432.86 USD). We found a negative correlation between total cost and age (p=0.001), and a positive correlation with duration of hospitalization (p=0.001) and number of complications (p=0.049). We were unable to find any relation of cost with sex and cerebrovascular accident type. Spasticity (p=0.028) and epilepsy (p=0.037) being among the complications were observed to increase the cost. CONCLUSION: Stroke is an important economic burden for Turkish population. Preventive social measures are necessary to reduce this cost.
OBJECTIVES: This study aims to estimate the annual economic cost per hemiplegic patient in Turkey. PATIENTS AND METHODS: Between September 2014 and December 2014, a total of 84 hemiplegic patients (53 males, 31 females; mean age 61.4±13.5 years; range 28-89 years) with stroke for 12 months were included in the study. Type of cerebrovascular accident and complications were evaluated. Hospital records and data from the relatives of the patients were used to calculate the cost. Annual costs were evaluated starting from first hospitalization. Direct costs were calculated with the sum of hospital care (acute care, diagnostic investigations, treatment and rehabilitation), medications, medical visits, outpatient rehabilitation and orthopedic aids. Indirect costs were calculated by taking the income loss due to absence from work into consideration. Prices of medical resources were obtained from the 2014 Healthcare Implementation Notification payment list. RESULTS: At the end of the study, the average direct cost and indirect cost per patient were calculated respectively as 10,594.90±6,554.20 Turkish liras and 9,357.10±10,195.60 Turkish liras (4,606.47±2,849.65 USD and 4,068.30±4,432.86 USD). We found a negative correlation between total cost and age (p=0.001), and a positive correlation with duration of hospitalization (p=0.001) and number of complications (p=0.049). We were unable to find any relation of cost with sex and cerebrovascular accident type. Spasticity (p=0.028) and epilepsy (p=0.037) being among the complications were observed to increase the cost. CONCLUSION: Stroke is an important economic burden for Turkish population. Preventive social measures are necessary to reduce this cost.
Authors: Peter L Kolominsky-Rabas; Peter U Heuschmann; Daniela Marschall; Martin Emmert; Nikoline Baltzer; Bernhard Neundörfer; Oliver Schöffski; Karl J Krobot Journal: Stroke Date: 2006-03-30 Impact factor: 7.914
Authors: Helen M Dewey; Amanda G Thrift; Cathy Mihalopoulos; Robert Carter; Richard A L Macdonell; John J McNeil; Geoffrey A Donnan Journal: Stroke Date: 2003-09-11 Impact factor: 7.914
Authors: Silvia M A A Evers; Jeroen N Struijs; André J H A Ament; Marianne L L van Genugten; J Hans C Jager; Geertrudis A M van den Bos Journal: Stroke Date: 2004-04-08 Impact factor: 7.914
Authors: Seung-Ji Lim; Han-Joong Kim; Chung-Mo Nam; Hoo-Sun Chang; Young Hwa Jang; Sera Kim; Hye Young Kang Journal: J Prev Med Public Health Date: 2009-07
Authors: Ana Paula Gaspari; Elaine Drehmer de Almeida Cruz; Josemar Batista; Francine Taporosky Alpendre; Viviane Zétola; Marcos Christiano Lange Journal: Rev Lat Am Enfermagem Date: 2019-10-14
Authors: Thinni Nurul Rochmah; Indana Tri Rahmawati; Maznah Dahlui; Wasis Budiarto; Nabilah Bilqis Journal: Int J Environ Res Public Health Date: 2021-07-15 Impact factor: 3.390